RT Journal Article
SR Electronic
T1 When mistrust in the government and scientists reinforce social inequalities in vaccination against Covid-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.02.23.22271397
DO 10.1101/2022.02.23.22271397
A1 Nathalie Bajos
A1 Alexis Spire
A1 Léna Silberzan
A1 Antoine Sireyjol
A1 Florence Jusot
A1 Laurence Meyer
A1 Jeanna-Eve Franck
A1 Josiane Warszawski
A1 the EpiCov study group
YR 2022
UL http://medrxiv.org/content/early/2022/02/24/2022.02.23.22271397.abstract
AB Objective To assess whether mistrust in the government and scientists reinforces social and racial inequalities in vaccination practisesDesign A follow-up of a random population-based cohort survey.Setting In July 2021, in France.Participants 80,971 participants aged 18 years and more.Main outcome measures Adjusted odds ratios of Covid-19 vaccination status (received at least one dose/ intends to get vaccinated/ does not know whether to get vaccinated/refuses vaccination) were assessed using multinomial regressions to test associations with social and mistrust factors and to study how these two factors interacted with each other.Results In all, 72.2% were vaccinated at the time of the survey. The population of unvaccinated people was younger, less educated, had lower incomes, and more often belonged to racialised minorities, as compared to vaccinated people. Mistrust of government and scientists to curb the spread of the epidemic were the factors most associated with refusing to be vaccinated: OR=8.86 (7.13 to 11.00) for the government and OR=9.07 (7.71 to 10.07) for scientists, compared to vaccinated people. Mistrust was more prevalent among the poorer which consequently reinforced social inequalities in vaccination. The 10% poorest who did not trust the government reached an OR of 16.2 (11.9 to 22) for refusing to be vaccinated compared to the 10% richest who did.Conclusion There is a need to develop depoliticised outreach programmes targeted at the most socially disadvantaged groups, and to design vaccination strategies conceived with people from different social and racial backgrounds to enable them to make fully informed choices.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by Inserm (Institut National de la Sante et de la Recherche Medicale) and Drees (Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques) Pr. Bajos has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. [856478]) This project has also received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 101016167, ORCHESTRA (Connecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic). Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for this work was given by the CNIL (French independent administrative authority responsible for data protection) on 25 April 2020 (ref: MLD/MFI/AR205138) and by the "Comite de protection des personnes" (French equivalent of the Research Ethics Committee) on 24 April. The survey also obtained an agreement from the "Comite du Label de la statistique publique", proving its adequacy to statistical quality standards.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymous aggregated data for the first round are available online. The EpiCov dataset is available for research purpose concerning the first round, and will be available by March 2022 concerning the second round for research purpose on CASD (https://www.casd.eu/), after submission to approval of French Ethics and Regulatory Committee procedure (Comite du Secret Statistique, CESREES and CNIL). Access to anonymized individual data underlying the findings may be available before the planned period, on request to the corresponding author, to be submitted to approval of the ethics and reglementary Committee for researchers who meet the criteria for access to data.